In the S-HFD group, which was subcutaneously injected with SCD1-knockdown (SCD1-KD) OVCAR5 cells, tumor growth was significantly inhibited compared with that in the NFD group (SCD1-KD and S-HFD vs. SCD1-KD and NFD; 0.125 g vs. 0.240 g, p = 0.006494; Fig. 6b, c). The gene discussed is SCD; the disease is neoplasm.